인쇄하기
취소

Hanmi to launch dexibuprofen syrup from next month

Published: 2006-12-26 06:58:00
Updated: 2006-12-26 06:58:00
Hanmi Pharm said its independently developed Maxibufen (dexibuprofen) syrup, an analgesic and antipyretic agent, will be available from January 2007.

Half dose of Maxibufen syrup has proven at least comparable efficacy to the full dose of ibuprofen syrup even in a 50-percent dose, with less nephrotoxicity and hepatotoxicity. Currently, dexibuprofen for oral solid administration is available ...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.